Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bouwman

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|September 22, 2021
A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination RepairEmilia M Pulver, Chirantani Mukherjee, Gerarda van de Kamp, et al.
Nature|March 25, 2015
REV7 counteracts DNA double-strand break resection and affects PARP inhibitionGuotai Xu, J Ross Chapman, Inger Brandsma, et al.
Frontiers in Toxicology|July 26, 2023
New approach methodologies to facilitate and improve the hazard assessment of non-genotoxic carcinogens-a PARC projectMarc Audebert, Ann-Sophie Assmann, Amaya Azqueta, et al.
The Journal of Clinical Investigation|July 26, 2016
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1Rinske Drost, Kiranjit K Dhillon, Hanneke van der Gulden, et al.
Cancer Research|May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and CisplatinYifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancer Research|September 22, 2021
A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination RepairEmilia M Pulver, Chirantani Mukherjee, Gerarda van de Kamp, et al.
Nature|March 25, 2015
REV7 counteracts DNA double-strand break resection and affects PARP inhibitionGuotai Xu, J Ross Chapman, Inger Brandsma, et al.
Frontiers in Toxicology|July 26, 2023
New approach methodologies to facilitate and improve the hazard assessment of non-genotoxic carcinogens-a PARC projectMarc Audebert, Ann-Sophie Assmann, Amaya Azqueta, et al.
The Journal of Clinical Investigation|July 26, 2016
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1Rinske Drost, Kiranjit K Dhillon, Hanneke van der Gulden, et al.
Cancer Research|May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and CisplatinYifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Pageof 5